Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$475K Sell
3,952
-800
-17% -$81.6K 0.19% 60
2026
Q2
$663K Buy
4,752
+877
+23% +$88.7K 0.27% 39
2026
Q1
$171K Sell
3,875
-1,015
-21% -$46.5K 0.08% 91
2025
Q4
$180K Hold
4,890
– – 0.08% 88
2025
Q3
$164K Buy
4,890
+743
+18% +$18K 0.08% 85
2025
Q2
$92.9K Buy
4,147
+250
+6% +$5.18K 0.05% 110
2025
Q1
$88.5K Buy
3,897
+300
+8% +$6.56K 0.05% 108
2024
Q4
$72.1K Sell
3,597
-109
-3% -$2.46K 0.04% 119
2024
Q3
$86.9K Buy
3,706
+752
+25% +$18.8K 0.05% 102
2024
Q2
$91.5K Buy
2,954
+250
+9% +$8.19K 0.06% 94
2024
Q1
$119K Sell
2,704
-300
-10% -$13.4K 0.08% 77
2023
Q4
$151K Buy
3,004
+584
+24% +$23.7K 0.1% 67
2023
Q3
$86K Sell
2,420
-100
-4% -$3.48K 0.08% 74
2023
Q2
$84.3K Sell
2,520
-360
-13% -$11.3K 0.07% 79
2023
Q1
$94.1K Buy
2,880
+250
+10% +$7.08K 0.09% 65
2022
Q4
$69.5K Sell
2,630
-1,207
-31% -$33.5K 0.07% 72
2022
Q3
$98.9K Buy
3,837
+130
+4% +$4.43K 0.11% 57
2022
Q2
$139K Hold
3,707
– – 0.14% 44
2022
Q1
$184K Hold
3,707
– – 0.16% 39
2021
Q4
$191K Buy
+3,707
New +$190K 0.14% 39

Other funds holding INTC

PFS Partners's INTC Position: Q3 2026 in Review

PFS Partners reduced its Intel (INTC) stake by 17% in Q3 2026, selling an estimated $81.6K and leaving 3,952 shares worth $475K. The position accounts for 0.19% of the portfolio, ranked #60.

PFS Partners first reported a position in INTC in Q4 2021 and has held it in 20 quarters since. The position peaked at $663K in Q2 2026. 910 funds tracked by Wall St. Rank hold INTC as of Q3 2026.

  • PFS Partners held 3,952 shares of Intel worth $475K as of Q3 2026.
  • PFS Partners sold 800 Intel shares in Q3 2026, an estimated $81.6K.
  • Intel made up 0.19% of PFS Partners's portfolio in Q3 2026, its #60 holding.
  • PFS Partners first reported a position in Intel in Q4 2021 and has held it in 20 quarters since.
  • PFS Partners's Intel position peaked at $663K in Q2 2026.
  • 910 funds tracked by Wall St. Rank held Intel as of Q3 2026.

Based on PFS Partners's 13F filing for Q3 2026, filed 21 Oct 2026.